The Liver Group
The Liver Group
SMALL CHARITY, BIG ASPIRATIONS
Our Aim: To fund research into the development of the Bioartificial Liver Machine and save millions of lives worldwide
The aim of The Liver Group Charity is to improve the treatment of liver disease through research, with our particular thrust into the development of the Bioartificial Liver. The research and development involved in achieving this long term aim necessarily – and beneficially - include the education and training of scientists and clinicians in the field, as well as the actual research both at the laboratory and the clinical interface.
Every year in the UK more than three thousand people die of liver failure, and world wide this affects millions. Liver disease is the only disease which is rising in the UK today, whilst organs available for liver transplant are declining and more than a third of people on the waiting list for transplant die before an organ becomes available.
Our bioartificial liver “buys time” for a sick liver to repair itself in patients with acute liver failure, so that a patient could leave hospital without the lifelong drug regime necessary after a transplant. Even in patients with chronic liver disease, who will inevitably need a whole new liver, the bioartificial liver will buy them time until a compatible new liver is available.
The Liver Group aims to:
- Provide relief to patients suffering from disease of the liver and genetic defects affecting the liver.
- Promote research into the causes and treatment of diseases of the liver on terms that the results of such research are published.
Established: May 1993
Registered Charity Number: 1024533
Board members: 9
Phone number: 02074332854
Address: The Liver Group Charity, C/O Dr Clare Selden, UCL Institute for Liver and Digestive Health (M19), Royal Free Hospital Campus, UCL Medical School, Upper Third floor, Rowland Hill St, Hampstead, London NW3 2PFView charity accounts on the Charity Commission website